Search research articles
Contact Us
Filters
Showing results (1-10 of 150) with videos related to
Page
of 15
Sort By:
The Journal of Infectious Diseases
|
February 23, 2010
HIV neutralizing antibodies: clinical correlates and implications for vaccines
Nicole A Doria-Rose
Current Opinion in HIV and AIDS
|
January 6, 2010
Antibody-secreting B cells in HIV infection
Nicole A Doria-Rose, Mark Connors
Current Opinion in HIV and AIDS
|
April 18, 2019
Coevolution of HIV-1 and broadly neutralizing antibodies
Nicole A Doria-Rose, Elise Landais
Current Opinion in Virology
|
April 28, 2015
Strategies to guide the antibody affinity maturation process
Nicole A Doria-Rose, M Gordon Joyce
Immunity
|
May 19, 2016
HIV Immunology Goes Out On a Limb
Nicole A Doria-Rose, John R Mascola
Methods (San Diego, Calif.)
|
September 27, 2003
DNA vaccine strategies: candidates for immune modulation and immunization regimens
Nicole A Doria-Rose, Nancy L Haigwood
Immunological Reviews
|
January 31, 2017
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies
Penny L Moore, Jason Gorman, Nicole A Doria-Rose, et al.
STAR Protocols
|
March 4, 2022
Protocol to identify and monitor key mutations of broadly neutralizing antibody lineages following sequential immunization of Ig-humanized mice
Xuejun Chen, Stephen D Schmidt, Hongying Duan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 29, 2025
An engineered antibody-lectin conjugate targeting the HIV glycan shield protects humanized mice against HIV challenge
Rashmi Kumariya, Jiadong Sun, Sabrina Lusvarghi, et al.
Virology
|
September 21, 2010
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells
Antonella Caivano, Nicole A Doria-Rose, Benjamin Buelow, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 150) with videos related to
Sort By:
Page
of 15
The Journal of Infectious Diseases
|
February 23, 2010
HIV neutralizing antibodies: clinical correlates and implications for vaccines
Nicole A Doria-Rose
Current Opinion in HIV and AIDS
|
January 6, 2010
Antibody-secreting B cells in HIV infection
Nicole A Doria-Rose, Mark Connors
Current Opinion in HIV and AIDS
|
April 18, 2019
Coevolution of HIV-1 and broadly neutralizing antibodies
Nicole A Doria-Rose, Elise Landais
Current Opinion in Virology
|
April 28, 2015
Strategies to guide the antibody affinity maturation process
Nicole A Doria-Rose, M Gordon Joyce
Immunity
|
May 19, 2016
HIV Immunology Goes Out On a Limb
Nicole A Doria-Rose, John R Mascola
Methods (San Diego, Calif.)
|
September 27, 2003
DNA vaccine strategies: candidates for immune modulation and immunization regimens
Nicole A Doria-Rose, Nancy L Haigwood
Immunological Reviews
|
January 31, 2017
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies
Penny L Moore, Jason Gorman, Nicole A Doria-Rose, et al.
STAR Protocols
|
March 4, 2022
Protocol to identify and monitor key mutations of broadly neutralizing antibody lineages following sequential immunization of Ig-humanized mice
Xuejun Chen, Stephen D Schmidt, Hongying Duan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 29, 2025
An engineered antibody-lectin conjugate targeting the HIV glycan shield protects humanized mice against HIV challenge
Rashmi Kumariya, Jiadong Sun, Sabrina Lusvarghi, et al.
Virology
|
September 21, 2010
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells
Antonella Caivano, Nicole A Doria-Rose, Benjamin Buelow, et al.
Page
of 15